First patient recruited to RADAR-CNS study

The RADAR-CNS (Remote Assessment of Disease and Relapse – Central Nervous System) project has recruited its first patient.

The patient, who is participating in the epilepsy component of RADAR-CNS, visited King’s College Hospital, London, UK, to receive initial guidance and testing using the Empatica E4, a wrist-worn wearable device.

They will initially participate in the study for three days, wearing the device 24 hours per day.  The device will capture information about the patient’s heart activity, movements, sweating and body temperature.  Information collected from the study will be captured and analysed using the RADAR-CNS software platform.

Researchers working on the epilepsy element of the RADAR-CNS study hope to recruit around 90 more patients over the coming months.  The depression and multiple sclerosis (MS) elements of the study are also planning to start recruiting patients in the coming months.

Information gathered during these early stages of the study will be used to test and refine the RADAR-CNS platform, with results and feedback from participants being used to improve the later stages of the five-year study.

According to Professor Mark Richardson from King’s College London, who co-leads the epilepsy component of the study, “The involvement of patients and people with experience of epilepsy, depression and MS is absolutely central to RADAR-CNS, and it’s very exciting to have reached the milestone of recruiting our first patient.”

Ultimately, RADAR-CNS aims to use information from wearable devices and smartphones to improve patients’ quality of life, and potentially to change how these and other chronic disorders are treated.